CLINICAL_TRIALS
trial_result
· 2016-10-10
Clinical Trial Update: Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients [Phase 3]
Summary
Phase 3 study of DW-330SR2 and pelubiprofen for chronic back pain has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Chronic Back Pain | Phase 3 | Status: COMPLETED